Bontempi Marco
Struttura Complessa Scienze e Tecnologie Chirurgiche, IRCCS Istituto Ortopedico Rizzoli, via di Barbiano 1/10, I-40136, Bologna, BO, Italy.
J Pharmacokinet Pharmacodyn. 2022 Jun;49(3):271-282. doi: 10.1007/s10928-021-09783-8. Epub 2021 Oct 15.
The International Normalized Ratio (INR) monitoring is an essential component to manage thrombotic disease therapy. This study presents a semi-empirical model of INR as a function of time and assigned therapy (Warfarin, k-vitamin). With respect to other methodologies, this model is able to describe the INR using a limited number of parameters and is able to describe the time variation of INR described in the literature. The presented methodology showed great accuracy in model calibration [(trueness (precision)]: 0.2% (0.1%) to 1.2% (0.3%) for coagulation factors, from 5% (9%) to 9.7% (12%) for Warfarin-related parameters and 38% (40%) for K-vitamin-related parameters. The latter value was considered acceptable given the assumptions made in the model. It has two other important results: the first is that it was able to correctly estimate INR with respect to daily therapy doses taken from the literature. The second is that it introduces a single numeric semi-empirical parameter that is able to correlate INR/dose response to physiological and environmental condition of patients.
国际标准化比值(INR)监测是血栓性疾病治疗管理的重要组成部分。本研究提出了一种INR的半经验模型,该模型是时间和指定治疗(华法林、维生素K)的函数。与其他方法相比,该模型能够用有限数量的参数描述INR,并能够描述文献中所述的INR随时间的变化。所提出的方法在模型校准[(准确性(精密度))]方面显示出很高的精度:凝血因子为0.2%(0.1%)至1.2%(0.3%),华法林相关参数为5%(9%)至9.7%(12%),维生素K相关参数为38%(40%)。考虑到模型中所做的假设,后一个值被认为是可以接受的。它还有另外两个重要结果:第一个是它能够根据从文献中获取的每日治疗剂量正确估计INR。第二个是它引入了一个单一的数值半经验参数,该参数能够将INR/剂量反应与患者的生理和环境状况相关联。